Clifford Law Offices Provides Free CLE Program Clifford Law Offices is hosting its annual Continuing Legal Education Program on Thursday, June 13, 2024, at 3:00 p.m. CST. Register now.
Free Consultation (312) 899-9090
Select Language

    Robert A. Clifford Writes Article for Chicago Lawyer About the Role of PAC Donations in the Opioid Crisis

    Find out if you have case
    Posted on April 23, 2021 To
    Robert A. Clifford Writes Article for Chicago Lawyer About the Role of PAC Donations in the Opioid Crisis

    clo-follow-the-money-instagramFounder and Senior Partner Robert A. Clifford of Clifford Law Offices, wrote an article titled, “Follow the Money” for Chicago Lawyer Magazine’s April/May 2021 edition.

    In the article, Bob writes about how addiction to prescribed pain medications, or opioids, has risen dramatically in the past two decades with over 400,000 people across the nation dying from the opioid epidemic.

    Last May, the Clifford Tort Symposium brought together the best academic minds to “discuss the various facets of this complex issue” and noted that “Dark Money” groups, who have received contributions from pharmaceutical companies that have made billions from opioid prescriptions, made substantial contributions to lawmakers through Political Action Communities (PACs) due, in large part, to the U.S. Supreme Court’s ruling in Citizens United v. Federal Election Commission, 558 U.S. 310 (2010) which loosened the rules for corporate political spending and allows nonprofit groups to engage in political activities without revealing funding sources or agendas.

    Bob expanded on the topic, “The problem remains the dark money of pharmaceutical companies that have deliberately funded the overuse of opioid drugs with a web that snared patients, health care professionals, patient advocacy groups, medical professional societies, medical research universities, public health agencies and elected officials at the state and federal levels.”

    The fight against pharmaceutical companies has started in the courts, with a landmark opioid trial in Oklahoma (late 2019) where Johnson & Johnson was ordered to reimburse the state $465 million for overselling the benefits of painkillers. While many cases similar to this will follow suit, Bob comments, “Much is still left to be done to resolve this crisis, and it will take a lot of cooperation and accountability to try to right this wrong.”

    To read the full article, click here.